Circulating Tumor DNA in High Risk Localized Prostate Cancer
NCT07222436 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2025-10-29
Summary
This prospective, non-therapeutic translational biomarker study will collect blood in patients with high risk localized prostate cancer prior to prostatectomy.
Conditions
Sponsors & Collaborators
-
The Beckwith Institute
collaborator OTHER -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Leonard J Appleman, MD, PhD · UPMC Hillman Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-23
- Primary Completion
- 2027-09-30
- Completion
- 2027-09-30
Countries
- United States
Study Locations
More Related Trials
-
Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology
NCT02022904 ·Status: WITHDRAWN ·Phase: NA
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING
-
Genetic Biomarker Discovery for Metastatic Prostate Cancer
NCT03228810 ·Status: COMPLETED
-
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
NCT01961713 ·Status: RECRUITING
-
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223
NCT02981797 ·Status: COMPLETED
-
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
NCT02735252 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
NCT00851682 ·Status: TERMINATED ·Phase: NA
-
Investigation of Protein Biomarkers of Prostate Cancer
NCT00323180 ·Status: WITHDRAWN
-
Study of Focal Cryoablation in Low-Risk Prostate Cancer
NCT00774436 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer
NCT02479945 ·Status: COMPLETED ·Phase: NA
-
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 ·Status: UNKNOWN
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
NCT01800058 ·Status: COMPLETED
-
Identification of Predictive Biomarkers
NCT04324983 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer
NCT05533515 ·Status: COMPLETED
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy
NCT02597894 ·Status: WITHDRAWN ·Phase: NA
-
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
NCT03494803 ·Status: WITHDRAWN